These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15118762)

  • 1. Histone deacetylase inhibitors upregulate expression of the coxsackie adenovirus receptor (CAR) preferentially in bladder cancer cells.
    Sachs MD; Ramamurthy M; Poel Hv; Wickham TJ; Lamfers M; Gerritsen W; Chowdhury W; Li Y; Schoenberg MP; Rodriguez R
    Cancer Gene Ther; 2004 Jul; 11(7):477-86. PubMed ID: 15118762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of increased coxsackie and adenovirus receptor gene expression and adenovirus uptake by phytoestrogen and histone deacetylase inhibitor in human bladder cancer cells and the potential clinical application.
    Pong RC; Roark R; Ou JY; Fan J; Stanfield J; Frenkel E; Sagalowsky A; Hsieh JT
    Cancer Res; 2006 Sep; 66(17):8822-8. PubMed ID: 16951199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro efficacy of AdTRAIL gene therapy of bladder cancer is enhanced by trichostatin A-mediated restoration of CAR expression and downregulation of cFLIP and Bcl-XL.
    El-Zawahry A; Lu P; White SJ; Voelkel-Johnson C
    Cancer Gene Ther; 2006 Mar; 13(3):281-9. PubMed ID: 16167063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells.
    Watanabe T; Hioki M; Fujiwara T; Nishizaki M; Kagawa S; Taki M; Kishimoto H; Endo Y; Urata Y; Tanaka N; Fujiwara T
    Exp Cell Res; 2006 Feb; 312(3):256-65. PubMed ID: 16356494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced transgene expression in urothelial cancer gene therapy with histone deacetylase inhibitor.
    Okegawa T; Nutahara K; Pong RC; Higashihara E; Hsieh JT
    J Urol; 2005 Aug; 174(2):747-52. PubMed ID: 16006969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced adenovirus transgene expression in malignant cells treated with the histone deacetylase inhibitor FR901228.
    Kitazono M; Goldsmith ME; Aikou T; Bates S; Fojo T
    Cancer Res; 2001 Sep; 61(17):6328-30. PubMed ID: 11522619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A histone deacetylase inhibitor enhances adenoviral infection of renal cancer cells.
    Okegawa T; Sayne JR; Nutahara K; Pong RC; Saboorian H; Kabbani W; Higashihara E; Hsieh JT
    J Urol; 2007 Mar; 177(3):1148-56. PubMed ID: 17296436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase inhibitors enhance Ad5-TRAIL killing of TRAIL-resistant prostate tumor cells through increased caspase-2 activity.
    VanOosten RL; Earel JK; Griffith TS
    Apoptosis; 2007 Mar; 12(3):561-71. PubMed ID: 17195089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose etoposide enhances telomerase-dependent adenovirus-mediated cytosine deaminase gene therapy through augmentation of adenoviral infection and transgene expression in a syngeneic bladder tumor model.
    Shieh GS; Shiau AL; Yo YT; Lin PR; Chang CC; Tzai TS; Wu CL
    Cancer Res; 2006 Oct; 66(20):9957-66. PubMed ID: 17047058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproic acid, a histone deacetylase inhibitor, is an antagonist for oncolytic adenoviral gene therapy.
    Höti N; Chowdhury W; Hsieh JT; Sachs MD; Lupold SE; Rodriguez R
    Mol Ther; 2006 Dec; 14(6):768-78. PubMed ID: 16990052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic regulation of coxsackie and adenovirus receptor (CAR) gene promoter in urogenital cancer cells.
    Pong RC; Lai YJ; Chen H; Okegawa T; Frenkel E; Sagalowsky A; Hsieh JT
    Cancer Res; 2003 Dec; 63(24):8680-6. PubMed ID: 14695181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanism of the growth-inhibitory effect of coxsackie and adenovirus receptor (CAR) on human bladder cancer: a functional analysis of car protein structure.
    Okegawa T; Pong RC; Li Y; Bergelson JM; Sagalowsky AI; Hsieh JT
    Cancer Res; 2001 Sep; 61(17):6592-600. PubMed ID: 11522659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium butyrate increases expression of the coxsackie and adenovirus receptor in colon cancer cells.
    Küster K; Grötzinger C; Koschel A; Fischer A; Wiedenmann B; Anders M
    Cancer Invest; 2010 Mar; 28(3):268-74. PubMed ID: 19863349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrin alpha(v) and coxsackie adenovirus receptor expression in clinical bladder cancer.
    Sachs MD; Rauen KA; Ramamurthy M; Dodson JL; De Marzo AM; Putzi MJ; Schoenberg MP; Rodriguez R
    Urology; 2002 Sep; 60(3):531-6. PubMed ID: 12350512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy.
    Li Y; Pong RC; Bergelson JM; Hall MC; Sagalowsky AI; Tseng CP; Wang Z; Hsieh JT
    Cancer Res; 1999 Jan; 59(2):325-30. PubMed ID: 9927041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CAR is a cell-cell adhesion protein in human cancer cells and is expressionally modulated by dexamethasone, TNFalpha, and TGFbeta.
    Brüning A; Runnebaum IB
    Gene Ther; 2003 Feb; 10(3):198-205. PubMed ID: 12571626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cox-2 promoter-based replication-selective adenoviral vector to target the cox-2-expressing human bladder cancer cells.
    Shirakawa T; Hamada K; Zhang Z; Okada H; Tagawa M; Kamidono S; Kawabata M; Gotoh A
    Clin Cancer Res; 2004 Jul; 10(13):4342-8. PubMed ID: 15240520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproic acid inhibits invasiveness in bladder cancer but not in prostate cancer cells.
    Chen CL; Sung J; Cohen M; Chowdhury WH; Sachs MD; Li Y; Lakshmanan Y; Yung BY; Lupold SE; Rodriguez R
    J Pharmacol Exp Ther; 2006 Nov; 319(2):533-42. PubMed ID: 16868035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trans-complementation of vector replication versus Coxsackie-adenovirus-receptor overexpression to improve transgene expression in poorly permissive cancer cells.
    Fechner H; Wang X; Wang H; Jansen A; Pauschinger M; Scherübl H; Bergelson JM; Schultheiss HP; Poller W
    Gene Ther; 2000 Nov; 7(22):1954-68. PubMed ID: 11127584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of novel histone deacetylase inhibitors, CHAP31 and FR901228 (FK228), on adenovirus-mediated transgene expression.
    Taura K; Yamamoto Y; Nakajima A; Hata K; Uchinami H; Yonezawa K; Hatano E; Nishino N; Yamaoka Y
    J Gene Med; 2004 May; 6(5):526-36. PubMed ID: 15133763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.